L & S Advisors Inc

Position in AZN — Astrazeneca PLC

CIK 1392364 Los Angeles, CA

Position in AZN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,616,488

-$40,467 QoQ

Shares Held

24,346

+3.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

#404

of 1,459 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

L & S Advisors Inc holds $46,126,033 across 5 Drug Manufacturers - General names. AZN ranks #5 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,439	$14,919,711
2	JNJ	Johnson & Johnson	52,966	$13,451,775
3	ABBV	AbbVie Inc.	30,958	$7,790,271
4	AMGN	Amgen Inc	14,768	$5,347,788
5	AZN	Astrazeneca PLC This page	24,346	$4,616,488

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,616,488	24,346	+3.1%	Shares	Sole	2026-08-12
2026-03-31	$4,656,955	23,613	-72.1%	Shares	Sole	2026-05-11
2025-12-31	$7,785,643	84,691	—	Shares	Sole	2026-02-05
No filing history on record for this holder in this stock.